Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7030 per ML under NDC 68462042121. Its NADAC has been published 385 times since Feb 13, 2019.
Strength
750 mg/5mL
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462042121
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA209685On Market Since
12/31/2017
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 385 times since Feb 13, 2019, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7030 per ML |
|---|---|
| All-time high | $3.1757 (Nov 13, 2019) |
| All-time low | $0.6910 (May 20, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6910 |
| Median price | $1.0827 |
| Average price | $1.2849 |
| Largest weekly change | +55.5% (Jan 20, 2021) |
| Weeks tracked | 385 |
| Tracking since | Feb 13, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7030 per ML (NDC 68462042121), effective Jun 24, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 73.2%. It has been tracked across 385 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Feb 13, 2019, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6910 (May 20, 2026) to a high of $3.1757 (Nov 13, 2019), with a median of $1.0827 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ATOVAQUONE 750 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 68462042121) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification